Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CILP Polyclonal Antibody

Catalog #:   PHB15301 Specific References (10) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: O75339
Overview

Catalog No.

PHB15301

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CILP (Ile603-Ala846).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

CILP-1, Cartilage intermediate-layer protein, Cartilage intermediate layer protein 1, CILP

Purification

Purified by antigen affinity column.

Accession

O75339

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CILP antibody (PHB15301) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 54 kDa
    Observed MW: 54 kDa
References

Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients., PMID:39492692

Comparison of Antigen Retrieval Methods for Immunohistochemical Analysis of Cartilage Matrix Glycoproteins Using Cartilage Intermediate Layer Protein 2 (CILP-2) as an Example., PMID:39311368

Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field., PMID:38880415

Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis., PMID:37993439

The prevalence of autoantibodies against cartilage intermediate layer protein, YKL-39, osteopontin, and cyclic citrullinated peptide in patients with early-stage knee osteoarthritis: evidence of a variety of autoimmune processes., PMID:15378262

Characterisation of cartilage intermediate layer protein (CILP)-induced arthropathy in mice., PMID:14962958

Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease., PMID:12180739

Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging., PMID:11341331

Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis., PMID:11315923

A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age., PMID:9722583

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CILP Polyclonal Antibody [PHB15301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only